ABSTRACT BACKGROUND One of the most common causes of juvenile blindness that is
avoidable is retinopathy of prematurity (ROP). As more extremely preterm newborns survive�…

Retinopathy of prematurity (ROP) is an alteration in the development of the immature retina
vascularization that frequently occurs in premature infants and is one of the leading causes�…

Purpose To focus on the longitudinal evaluation of high-risk infants for the development of
retinopathy of prematurity (ROP) at a single tertiary neonatal intensive care unit (NICU), and�…

AIM To compare the efficacy and safety between laser therapy and anti-vascular endothelial
growth factor (VEGF) agents intravitreal injection monotherapy in type-1 retinopathy of�…

Purpose To compare rates of short-term retinal detachment (RD) of infants treated for type 1
retinopathy of prematurity (ROP) with intravitreal anti–vascular endothelial growth factor�…

Retinopathy of prematurity treatment modalities have expanded over the years, from
cryotherapy to laser therapy and now, anti-vascular endothelial factor (VEGF) therapy by�…

BACKGROUND AND OBJECTIVE: To evaluate neurodevelopmental outcomes among
infants treated for retinopathy of prematurity (ROP) at the authors' institution. PATIENTS AND�…

The aim of this study is to investigate the epidemiology of ophthalmic complications of
retinopathy of prematurity (ROP) after preterm birth using population-based database in�…

We investigate the efficacy and safety of intravitreal injection (IVI) of antivascular endothelial
growth factor agents and laser photocoagulation (LPC) for retinopathy of prematurity. We�…

Purpose To provide an overview of the impact of retinopathy of prematurity (ROP), and the
challenges in the screening, diagnosis, and treatment of ROP worldwide. Methods A�…